SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Space Exploration Technologies Corp., doing business as SpaceX, operates as an aerospace manufacturer, launch service provider, and satellite communications company. It is building the integrated hardware and software infrastructure of the future across space, connectivity, and AI. The firm designs, manufactures, launches, and operates products and services built on cutting-edge technologies, including the rockets and spacecraft. The company was founded by Elon Reeve Musk in 2002 and is headquartered in Starbase, TX.

Space Exploration Technologies Corp. - Ordinary Shares - Class A

SpaceX

SpaceXs strong third-quarter results and rapid AI-compute growth, alongside Musks ambitious revenue outlook, are driving attention. Bulls see further growth potential, while skeptics question the valuation, heavy capital spending and credibility of the targets.

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Super Micros preliminary fiscal first-quarter update sharply raised its revenue outlook and projected stronger gross margins on increased AI-platform demand, prompting a strong after-hours rally. Traders largely celebrated the upside surprise and speculated about short covering, while others questioned whether the improvement will be sustained and warned that the volatile stock could give back gains.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflixs quarterly results beat profit expectations, but softer fourth-quarter guidance and a reduced advertising outlook have intensified concerns about slowing revenue growth. Traders are divided between viewing the selloff as an overreaction and buying the dip, and arguing that competition and weaker engagement leave the company without a clear growth engine.

GE Aerospace is an American aircraft company, which engages in the provision of jet and turboprop engines, as well as integrated systems for commercial, military, business, and general aviation aircraft. The firm's portfolio of brands includes Avio Aero, Unison, GE Additive, and Dowty Propellers. It operates through the following segments: Commercial Engines and Services, Defense and Propulsion Technologies, and Corporate and Other. The Commercial Engines and Services segment is involved in the design, development, manufacturing, and servicing of jet engines for commercial airframes, as well as business aviation and aeroderivative applications. The Defense and Propulsion Technologies segment offers defense engines and critical aircraft systems. The Corporate and Other segment relates to corporate functions and operations costs. The company was founded by Thomas Alva Edison in 1878 and is headquartered in Evendale, OH.

GE Aerospace

GEs quarterly earnings beat and higher 2026 guidance were met with a sharp selloff, as traders focused on rising costs, weaker cash conversion, supply constraints and an insurance loss. The reaction has frustrated bullish holders who see strong demand and backlog, while others argue high expectations and valuation made the beat insufficient to lift the shares.

TOSHI

TOSHIs rebound and rising volume have traders focused on whether it can break through a repeatedly tested resistance area, with bullish posts anticipating a breakout or short squeeze. Others remain cautious after failed attempts and point to broader crypto weakness; speculation about a surprise announcement or listing is unconfirmed.

Redwire Corp. engages in the development and provision of space and defense technologies and mission-critical solutions for government, commercial, and civil customers. Its offerings include spacecraft platforms, space infrastructure, avionics, sensors and payloads, power generation systems, radio frequency systems, microgravity research and manufacturing technologies, autonomous systems, optical sensors, and digital engineering solutions. The company was founded in 2020 and is headquartered in Jacksonville, FL.

Redwire Corporation

Redwire Corp

Anticipation around Redwires Q3 earnings is a major focus, with traders also weighing recent defense and space-contract wins against the stocks persistent weakness and broader pressure on space and small-cap shares. Bulls point to backlog, support levels and elevated short interest as reasons for a possible rebound, while bears question whether earnings can reverse the selloff.

Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Celsius Holdings Inc

A cluster of recent insider purchases is drawing attention, with bulls viewing the buying as a sign of confidence and a possible bottom while skeptics point to CELHs weak share performance and uncertain growth. Traders are also watching whether the stock can hold above $30, amid debate over the core Celsius brands sales trends, Alani Nus growth, and speculative Pepsi buyout talk.

Fervo Energy Co. operates as a energy company. It builds and operates power facilities in extracting geothermal energy. The company was founded by Jack Norbeck and Timothy Latimer in 2017 and is headquartered in Berkeley, CA.

Fervo Energy Co. - Ordinary Shares - Class A

Fervo Energy Co

FRVO is drawing attention amid a sharp selloff and debate over a bearish short report that questions the economics and technical performance of its enhanced geothermal systems, including water recovery. Bulls argue that Cape Stations move to commercial power generation and Googles contracted demand support the business, while skeptics remain focused on execution and transmission constraints.

Disc Medicine, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of treatments for hematologic diseases. It assembles a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. The company was founded in October 2017 and is headquartered in Watertown, MA.

Disc Medicine Inc

Disc Medicines shares are drawing attention after bitopertins Phase 3 APOLLO trial met its endpoints and the company priced an upsized public offering. Traders are weighing the stronger regulatory prospects against dilution and potential selling pressure from the financing.

Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. Its products include Da Vinci Surgical and Ion Endoluminal systems. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.

Intuitive Surgical Inc

Intuitive Surgicals Q3 results beat expectations, but shares sold off sharply as traders focused on slower U.S. procedure growth, planned da Vinci pricing cuts, and a one-time antitrust settlement. The community is split between calling the decline an overreaction to solid business growth and seeing the guidance and pricing pressures as reasons for caution.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Concerns about Oracles debt-heavy AI data-center buildout, rising credit risk and weak free cash flow dominate discussion, alongside pressure on AI infrastructure stocks. Traders are split between seeing the spending and backlog as a path to future cloud growth and fearing that borrowing costs and execution risks could overwhelm demand.

Here's Why Oracle (ORCL) is a Strong Value Stock

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Informatica Boosts Salesforce's Data Edge: Can It Unlock More Growth?

Informatica adds $456 million to Salesforce's Q2'27 revenues, strengthening its data and AI capabilities. Can this momentum fuel sustainable growth?

Oracle, AstraZeneca Explore AI To Tackle Clinical-Trial Recruitment Challenge

Equity

Oracle and AstraZeneca plan to explore AI applications to improve clinical-trial recruitment, accelerate evidence generation and bring research insights into everyday care.



SpaceX Faces Earnings Test Today: RBC Flags Over 50% Upside As Tesla Merger Buzz Builds, S&P Flags AI Financing Risks

S&P warned that interconnected AI financing structures may obscure liabilities, though it sees no immediate need for ratings changes.

BE Stock Slips Overnight: Bloom Energy’s Valuation In Focus Ahead Of Q3 Earnings

Bloom Energy's forward price-to-earnings ratio exceeds its peers, at 63.5x as per Koyfin data.

Oracle and AstraZeneca Partner to Advance AI-enabled Healthcare Innovation

Oracle and AstraZeneca Partner to Advance AI-enabled Healthcare Innovation Oracle and AstraZeneca Partner to Advance AI-enabled Healthcare InnovationPR NewswireAUSTIN, Texas and ABU DHABI, UAE, Oct. 20, 2026 Collaboration to connect AstraZeneca's scientific and therapeutic expertise with Oracle's...

BE Stock Adds 3% After Oracle Signals Project Jupiter 'Moving Quickly' 

Construction on the Project Jupiter data center campus is moving quickly, with strong progress on site, Oracle said in a post on X. 


Intuit to Acquire Sequence to Boost AI-Powered Mid-Market Offerings

INTU is set to acquire Sequence to enhance AI-powered revenue management, automate complex billing workflows and strengthen its mid-market ERP capabilities.

BE Stock Jumps Premarket Into Earnings Week: Retail Bets On 40% Pop As Wall Street Eyes Strong Q3 Growth

Analysts expect revenue to double year-over-year to $1.06 billion and adjusted EPS to rise to $0.70 from $0.15.

Why Oracle (ORCL) Dipped More Than Broader Market Today

Oracle (ORCL) closed at $128.51 in the latest trading session, marking a -4.43% move from the prior day.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Bearish Sentiment

<ul class="summary-bullets"><li>Oracle CEO Mike Sicilia said the collaboration could help accelerate research, connect more patients to clinical trials and bring relevant insights into care faster.&nbsp;</li><li>AstraZeneca CEO Pascal Soriot highlighted the potential to identify patients sooner, optimize trials and generate evidence throughout a medicine's lifecycle.</li><li>The companies plan to establish shared governance, reusable technical components and agreed outcome measures to assess results and determine whether successful approaches could be extended across disease areas and geographies.</li></ul>Oracle (ORCL) shares were in focus on Tuesday after the company announced an agreement with AstraZeneca (AZN) to explore how artificial intelligence (AI) and real-world data could help clinicians identify eligible patients for clinical trials, improve trial efficiency and bring relevant research insights into everyday care.“Some of the most important opportunities for AI are in healthcare, where better use of data can help turn scientific innovation into better outcomes for patients,” Oracle CEO Mike Sicilia said.<a href="https://stocktwits.com/symbol/ORCL">ORCL shares</a> traded 0.51% higher in premarket trading, while&nbsp;<a href="https://stocktwits.com/symbol/AZN">AZN shares</a> rose 1.76%, as of the time of writing on Tuesday.<h2 class="st-heading-2">What The Agreement Covers</h2>The non-binding agreement is expected to combine AstraZeneca’s scientific and therapeutic expertise with Oracle’s health data, cloud, AI, analytics and clinical workflow capabilities.The companies plan to explore selected use cases involving modern applications and AI to help care teams identify eligible patients earlier and more easily, with the aim of expanding access to clinical trials and addressing patient recruitment, which the companies describe as one of the largest obstacles in clinical trials.Initial disease areas under consideration could include oncology; cardiovascular, renal and metabolic diseases, respiratory and immunology, and rare diseases.<h2 class="st-heading-2">What Management Says</h2>AstraZeneca CEO Pascal Soriot said the collaboration could help clinicians identify patients sooner, optimize clinical trials and generate evidence continuously across the lifecycle of a medicine.Anne-Claire Gerbaldi, AstraZeneca’s chief digital, data and AI officer, said the companies aim to connect learnings across science, clinical trials and everyday care to generate insights that strengthen research, accelerate innovation and enhance patient outcomes. She also cited the potential to support smarter clinical trials, strengthen safety monitoring and help patients receive diagnoses sooner.Seema Verma, executive vice president and general manager of Oracle Health and Life Sciences, said Oracle would provide secure data, cloud, AI and clinical workflow capabilities. She said the collaboration could help health systems broaden access to clinical trials and generate evidence to support clinical decisions, under the governance of the health systems delivering care.<h2 class="st-heading-2">What Happens Next</h2>Oracle and AstraZeneca intend to explore a continuous learning model in which insights from clinical research and routine care inform future study design, safety monitoring and patient care.The companies also plan to establish shared governance, reusable technical components and agreed outcome measures to assess results and determine whether successful approaches could be extended across disease areas and geographies.<h2 class="st-heading-2">How Retail Views ORCL-AZN Partnership</h2>On Stocktwits, retail sentiment for ORCL remained in ‘bearish’ territory, despite ‘extremely high’ message volume over the past 24 hours. Whereas, retail sentiment for AZN remained ‘neutral’ amid ‘high’ message volumes in the past 24 hours.One user criticized Oracle's leadership and board oversight, blaming founder Larry Ellison and the company's co-CEOs for what the user described as poor management decisions. The user also called for independent directors to be voted off the board.<stembedurl>https://stocktwits.com/RohR1/message/666896449</stembedurl>Another bullish user said they had added ORCL to their long portfolio, citing its potential upside and saying the stock was difficult to ignore at current levels.<stembedurl>https://stocktwits.com/onlythebestcompanies/message/666893921</stembedurl>ORCL shares have fallen more than 33% year to date, while AZN shares have declined over 11% over the same period.Also read: <a href="https://stocktwits.com/news-articles/markets/equity/nvidia-rtx-pro-5500-china-orders-export-curbs/cZxqrcARBuZ">Nvidia Reportedly Sees Alibaba, ByteDance, Tencent Order $35B In RTX PRO 5500 Chips Amid US Export Curbs</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

 The logo of the software and hardware manufacturer Oracle can be seen at the German headquarters. 

Oracle (ORCL) shares were in focus on Tuesday after the company announced an agreement with AstraZeneca (AZN) to explore how artificial intelligence (AI) and real-world data could help clinicians identify eligible patients for clinical trials, improve tri

AstraZeneca PLC

Buying

Holding

Selling or trimming

Watching from the sidelines

AI infrastructure stocks are under pressure this week - what have you been doing?

Stocktwits

Stocktwits Polls

Rising CDS spreads and debt default concerns have investors debating if this is a systemic contagion for the entire AI trade.

Anticipation builds for the AI World conference and Investor Day in late October as traders look for news to reverse the stock's trend.

Frustrated holders are calling out the stock's sluggish relative strength as it struggles to hold key resistance levels amid broader market rallies.

Hope remains pinned on Project Jupiter reaching capacity soon as a potential catalyst for massive cloud infrastructure revenue.

Current Price	$131.14
Prev Close	$129.59
Open	$128.51
Dividend Yield	0.89%
50-Day Moving Average	$144.37
Beta	1.64
Avg. Volume	35.11M
PE Ratio	20.56

52-Week High	$287.19
52-Week Low	$114.50
Market Capitalization	$396.53B
EPS (Annual)	$5.83
Price to Book	6.42
Revenue Per Employee	$477,709.22

Feed

News

Sentiment

Earnings

NewFutures

Fundamentals

Info

ORCL Fundamentals